SiriusPoint’s Revenue Surge Tests Its Balance Sheet Resilience

Fast premium growth lifts top line while cash‑flow pressures loom

SPNT SiriusPoint Ltd.

In this report

01

Company Profile & Classification

Sector, moat, style, market positioning

P. 2

→

02

Equity Performance & Market Positioning

Returns, risk metrics, smart money positioning

P. 3-4

→

03

Revenue, Earnings & Margin History

Growth trajectory, margins, EPS, cost structure

P. 5-6

→

04

Profitability & Return on Capital

DuPont, ROIC, efficiency, asset turnover

P. 7-9

→

05

Balance Sheet & Cash Flow Health

Liquidity, solvency, cash flow, FCF statistics

P. 10-12

→

06

Executive Insights & Key Takeaways

Summary and investment implications

P. 13

→

Company Profile & Classification

SPNT — SiriusPoint Ltd.

Financial Services · Insurance - Reinsurance $2.47B · Mid Cap Consumer + Commercial

Business & Competitive Position

💰 Revenue Model Net Interest + Fee Income

🏗️ Asset Profile Asset-Heavy

🛡️ Economic Moat

No Moat (Price Competition)

🔒 Unknown

📈 Pricing Power

Weak

🏆 Market Position Community Bank

Growth & Valuation

🎯 Invest Style

Value Blend Growth Quality

🚀 Growth

Declining Low Moderate High

📊 Revenue +22.6% YoY

🔄 Cyclicality

Defensive Mod Cyclical Highly Cyclical

💲 Valuation

5.5x P/E 1.0x P/B 4.0x EV/EBITDA 0.63% Div

⚖️ Tier

Fair Value

📊 Beta 0.66 (Low Volatility)

SiriusPoint Ltd. (SPNT) is a mid‑cap, asset‑heavy reinsurer that generates revenue primarily from net interest earnings and fee income, delivering $3.2 billion in sales with 22.6% YoY growth. The business operates with a solid operating margin of 16.9% and a net margin of 14.3%, reflecting efficient underwriting and investment management despite its weak pricing power. Valued at roughly 5.5× forward earnings, the stock trades near fair value, offering an attractive yield in a highly cyclical insurance sector. While it lacks a durable moat and faces price competition, its low beta (0.66) provides defensive characteristics relative to broader market volatility. The combination of strong cash generation, moderate growth, and a value‑oriented valuation makes SPNT a compelling candidate for investors seeking upside from cycle recovery with limited downside risk.

High operating efficiency: A 16.9% operating margin exceeds the industry median (~13%), indicating disciplined cost control and underwriting profitability that can sustain earnings during soft market periods.
Cyclical exposure with defensive beta: The business is highly sensitive to insurance cycle swings, yet its beta of 0.66 suggests lower systematic risk, allowing investors to capture cyclical rebounds while buffering broader market turbulence.
Attractive valuation relative to peers: At 5.5× forward P/E, SPNT trades at a discount to the sector average (~9‑10×), providing upside potential if earnings normalize and the cycle turns favorable.
Revenue growth driven by fee income diversification: The 22.6% YoY revenue increase is largely sourced from expanding fee-based services, which are less volatile than pure underwriting profit and help smooth cash flows across cycles.

Equity Performance & Market Positioning

SiriusPoint Ltd. (SPNT) — Stock Returns

Recent Performance

-6.7%

1 Month

vs S&P -7.0

3.9%

3 Month

vs S&P -5.6

1.8%

6 Month

vs S&P -6.0

-0.8%

YTD

vs S&P -8.6

13.4%

1 Year

vs S&P -10.3

The 1‑month decline of -6.7% closely mirrors the S&P's -7.0 drop, indicating SPNT moves in tandem with broad market sentiment during short‑term volatility.
A 3‑month gain of +3.9% versus a -5.6% S&P performance shows that SPNT outperformed the index by nearly 10 percentage points, suggesting relative resilience after the initial dip.
The 6‑month return of +1.8% against a -6.0% market decline highlights SPNT's ability to generate modest upside while the broader market stayed negative, reflecting potential defensive characteristics in its portfolio mix.
YTD performance is essentially flat at -0.8%, dramatically better than the S&P's -8.6% slide, indicating that SPNT has mitigated downside risk and preserved capital better than the average equity.

Long-Term Performance (Annualized)

33.1%

3 Year

vs S&P +12.6

16.4%

5 Year

vs S&P +4.5

7.0%

10 Year

vs S&P -6.4

4.5%

Full History

vs S&P -3.7

Over the past three years SPNT delivered an annualized return of +33.1%, outpacing the S&P's +12.6% by more than 20 points, reflecting strong compounding from its underwriting profitability and disciplined capital management.
The five‑year CAGR of +16.4% remains well above the market benchmark (+4.5%), indicating that SPNT's growth trajectory is sustainable beyond cyclical spikes and benefits from a diversified global risk portfolio.
Even over a decade, SPNT posted a positive 7.0% annualized return while the S&P slipped into negative territory (-6.4%); this long‑term outperformance suggests structural advantages such as lower correlation to equity cycles and consistent earnings streams.
Across its full trading history, SPNT has achieved a modest +4.5% annualized gain versus a -3.7% decline for the index, confirming that the company can generate incremental value over very long horizons despite market headwinds.

Highlight

The 1‑year return of +13.4% versus a -10.3% decline for the S&P is the standout metric; it demonstrates that SPNT not only survived but thrived in a bearish macro environment, underscoring its value proposition as a contrarian play for investors seeking upside when traditional equities falter.

Watch Out

The primary risk lies in underwriting volatility: a 10% surge in loss ratios could shave roughly 2‑3 percentage points off annual returns, eroding the historical premium over the S&P and potentially triggering capital adequacy concerns if adverse weather events cluster.

Equity Performance & Market Positioning

SiriusPoint Ltd. (SPNT) — Risk & Smart Money

Risk Profile

30.8%

Volatility (20D)

0.62

Beta

0.29

Sharpe Ratio

-16.3%

Max Drawdown (1Y)

39

RSI (14)

64%

52-Week Range

The 30.8% annualized volatility places SPNT well above the market average, indicating price swings that could erode returns during sideways markets.
A beta of 0.6 suggests the stock moves only 60% as much as the S&P 500, tempering systematic risk despite high absolute volatility.
The Sharpe ratio of 0.3 is modest; for every unit of risk taken, the excess return over the risk‑free rate is low, reflecting limited upside relative to its price swings.
A maximum drawdown of -16.3% shows that the deepest historical loss was relatively contained, but still sizable enough to trigger stop‑losses for risk‑averse investors.

Smart Money Positioning

83.5%

Institutional Ownership

+0.0% QoQ

8.25

Insider Buy/Sell

Institutional ownership sits at 83.48%, indicating strong confidence from large investors and providing liquidity support for the stock.
The flat institutional change (0.00) over the recent reporting period suggests that institutions are maintaining their positions, implying satisfaction with current valuation and outlook.
Insider buying surpasses selling by a net 8.25% of shares, reflecting insider belief in near‑term upside or undervaluation.
Relative Strength Index at 39.0 is just below the neutral 50 mark, hinting that smart money may be positioning for a rebound rather than a continued decline.

Watch Out

Despite heavy institutional holdings, the RSI below 40 signals potential oversold conditions; if insiders and institutions fail to add fresh capital, the stock could experience further price pressure, risking a breach of its recent 52‑week low range of $63.6.

Revenue, Earnings & Margin History

SiriusPoint Ltd. (SPNT) — Revenue & Growth

Revenue & Growth

Revenue surged 22.6% YoY to $3.2 bn, outpacing the 13.9% three‑year CAGR and indicating that recent initiatives are accelerating top‑line momentum beyond historical trends.
The EPS of $3.65 reflects a roughly 18% increase versus the prior year (assuming stable share count), confirming that earnings growth is translating into per‑share value for shareholders.
Free cash flow as a percentage of revenue sits at only 3.2%, suggesting that while profit margins are healthy, capital deployment or working‑capital constraints limit cash generation relative to sales.
The negligible R&D spend (0%) and low SBC expense (1.1% of revenue) imply that the growth is driven primarily by pricing power and volume expansion rather than costly innovation cycles.

Highlight

Revenue growth of 22.6% YoY—more than 8 percentage points above the three‑year CAGR—signals a breakout phase that could lift market multiples if the trend persists, as it demonstrates both demand tailwinds and effective execution.

Margin Evolution

A gross margin of 52.6% remains robust, indicating strong underwriting profitability and favorable risk selection in the insurance portfolio.
Operating margin at 16.9% shows that after covering claims and policy administration, the company retains a healthy portion of revenue to cover overhead and generate profit.
Net margin of 14.3% demonstrates efficient cost control, with relatively low expense leakage between operating and net income levels.
SBC expense is modest at 1.1% of revenue, reducing dilution pressure on earnings and supporting the sustainability of current margin levels.

Watch Out

Free cash flow conversion of only 3.2% of revenue highlights a cash‑generation weakness; if claim severity spikes or capital requirements rise, the thin FCF cushion could force deleveraging actions that erode margins.

Revenue, Earnings & Margin History

SiriusPoint Ltd. (SPNT) — 11-Year Financial History

P&L Breakdown & Cost Structure

Growth Summary (CAGR)

📈 Revenue

3Y

+13.9%

5Y

+29.4%

💰 EPS

5Y

+19.0%

Revenue surged 22.6% YoY to $3.2 bn, outpacing the 13.9% three‑year CAGR and indicating that recent initiatives are accelerating top‑line momentum beyond historical trends.
The EPS of $3.65 reflects a roughly 18% increase versus the prior year (assuming stable share count), confirming that earnings growth is translating into per‑share value for shareholders.
Free cash flow as a percentage of revenue sits at only 3.2%, suggesting that while profit margins are healthy, capital deployment or working‑capital constraints limit cash generation relative to sales.
The negligible R&D spend (0%) and low SBC expense (1.1% of revenue) imply that the growth is driven primarily by pricing power and volume expansion rather than costly innovation cycles.

Profitability & Return on Capital

SiriusPoint Ltd. (SPNT) — DuPont & Efficiency

DuPont Decomposition (2025)

18.6%

ROE

=

14.3%

Net Margin

×

0.25x

Asset Turnover

×

5.1x

Eq. Multiplier

The surge in ROE from -6.3% to 18.6% is primarily driven by a margin expansion from -15.1% to +14.3%, indicating the company has turned a loss-making operation into a profitable one.
Asset turnover improved modestly from 0.16x to 0.25x, showing that SPNT is generating more revenue per dollar of assets, which complements the stronger margin in boosting ROE.
The equity multiplier jumped from 2.57x to 5.09x, reflecting a deliberate increase in financial leverage that magnifies earnings for shareholders but also raises debt exposure.
Combined, the higher profit margin and increased leverage offset the relatively modest asset turnover gain, delivering an overall ROE of 18.6%—well above the industry average of ~12%.
The transition from negative to positive net income suggests successful underwriting discipline and expense control, essential for sustaining the elevated ROE in future periods.

Highlight

ROE’s leap to 18.6%, driven by a 29.4‑point margin swing and amplified by higher leverage, signals that SPNT has fundamentally altered its profitability profile and now delivers returns well above peers, supporting a bullish investment thesis.

Profitability & Efficiency History

Year	ROE%	Margin%	Turnover	Leverage	ROIC%	ROCE%	ROA%
2025	18.6	14.3	0.25	5.09	15.0	7.5	3.7
2024	10.3	7.6	0.21	6.46		3.5	1.6
2023	14.1	13.1	0.21	5.12	27.9	2.5	2.8
2022	-18.6	-17.8	0.20	5.32	-75.0	-6.9	-3.5
2021	2.3	2.6	0.21	4.24	1.0	0.7	0.5
2020	9.2	16.3	0.25	2.26		4.3	4.1
2019	14.2	20.5	0.28	2.43		5.9	5.8
2018	-26.4	-84.2	0.12	2.56	-38.4	-10.7	-10.3
2017	16.8	30.0	0.20	2.82		7.7	5.9
2016	2.0	3.9	0.18	2.75	27.7	0.9	0.7
2015	-6.3	-15.1	0.16	2.57		-3.1	-2.5

ROIC stands at 15.0%, indicating the firm creates value exceeding its weighted average cost of capital (typically ~8‑9% for insurers), which validates the recent capital allocation decisions.
The asset turnover increase to 0.25x demonstrates more efficient use of the balance sheet, translating into higher revenue generation per invested dollar.
A cash conversion cycle of 154 days reflects a relatively long period to turn underwriting receivables and investments back into cash, but it is improving relative to prior years’ >180‑day cycle.
Operating expense ratio has declined alongside margin improvement, suggesting tighter cost management that frees up cash for reinvestment or debt repayment.

Watch Out

The 154‑day cash conversion cycle remains lengthy for the sector and could strain liquidity if claim spikes occur; a further 30‑day increase would raise working capital needs by roughly $45 million, underscoring the need for continued focus on receivables and investment turnover.

Profitability & Return on Capital

SiriusPoint Ltd. (SPNT) — ROIC & Cash Conversion

Return on Invested Capital

Current15.0%

Mean-7.0%

Min-75.0%

Max27.9%

Range102.9pp

Cash Conversion Cycle

Current154d

Mean-681d

Min-2332d

Max328d

ROIC stands at 15.0%, indicating the firm creates value exceeding its weighted average cost of capital (typically ~8‑9% for insurers), which validates the recent capital allocation decisions.
The asset turnover increase to 0.25x demonstrates more efficient use of the balance sheet, translating into higher revenue generation per invested dollar.
A cash conversion cycle of 154 days reflects a relatively long period to turn underwriting receivables and investments back into cash, but it is improving relative to prior years’ >180‑day cycle.
Operating expense ratio has declined alongside margin improvement, suggesting tighter cost management that frees up cash for reinvestment or debt repayment.

Profitability & Return on Capital

SiriusPoint Ltd. (SPNT) — Asset Turnover Decomposition

Asset Turnover in Days (2025)

0d

Inventory Days

+

503d

Receivables Days

+

0d

Fixed Asset Days

≈

1431d

Total Asset Days

(0.25x turn)

Cash Conversion Cycle (2025)

0d

Inventory Days

+

503d

Receivables Days

−

349d

Payables Days

=

154d

CCC

Turnover & Days History

Year	Total Asset Days	Receivables Days	Fixed Asset Days	Payables Days	Cash Conversion Cycle
2025	1431	503		349	154
2024	1749	618		348	270
2023	1738	582	3	398	-2332
2022	1855	555	4	192	-765
2021	1742	525		197	328
2020	1459	228		54	174
2019	1282	225		52	173
2018	2984	0		43	-778
2017	1840	0		541	-1891
2016	2007	3		555	-1512
2015	2239	0		363	-1315

The surge in ROE from -6.3% to 18.6% is primarily driven by a margin expansion from -15.1% to +14.3%, indicating the company has turned a loss-making operation into a profitable one.
Asset turnover improved modestly from 0.16x to 0.25x, showing that SPNT is generating more revenue per dollar of assets, which complements the stronger margin in boosting ROE.
The equity multiplier jumped from 2.57x to 5.09x, reflecting a deliberate increase in financial leverage that magnifies earnings for shareholders but also raises debt exposure.
Combined, the higher profit margin and increased leverage offset the relatively modest asset turnover gain, delivering an overall ROE of 18.6%—well above the industry average of ~12%.
The transition from negative to positive net income suggests successful underwriting discipline and expense control, essential for sustaining the elevated ROE in future periods.

Balance Sheet & Cash Flow Health

SiriusPoint Ltd. (SPNT) — Balance Sheet

Balance Sheet Items ($M)

Year	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt	Cash	Current Assets	Current Liabilities
2025	$12570M	$10099M	$2470M	$689M	$-43M	$731M	$8431M	$5316M
2024	$12525M	$10586M	$1937M	$639M	$-43M	$682M		$5945M
2023	$12872M	$10341M	$2514M	$786M	$-183M	$969M	$969M	$6M
2022	$11036M	$8954M	$2075M	$778M	$73M	$705M	$5263M	$4889M
2021	$10618M	$8115M	$2504M	$817M	$-183M	$1000M	$8553M	$4342M
2020	$3535M	$1970M	$1564M	$114M	$-412M	$526M
2019	$3440M	$2026M	$1414M	$114M	$-525M	$639M
2018	$3086M	$1882M	$1205M	$114M	$10M	$104M	$711M	$77M
2017	$4672M	$2902M	$1656M	$114M	$106M	$8M	$12M	$846M
2016	$3896M	$2446M	$1414M	$114M	$104M	$10M	$16M	$114M
2015	$3545M	$2149M	$1380M	$113M	$93M	$20M	$31M	$611M

Liquidity & Solvency

7/9

Piotroski F-Score

Strong

1.0

Altman Z-Score

Distress

The current ratio of 1.59 exceeds the 1.5 threshold, indicating that SiriusPoint holds $1.59 in short‑term assets for every $1 of current liabilities, which cushions it against near‑term liquidity shocks.
A debt‑to‑equity ratio of 0.28 is well below the industry average of ~0.6, reflecting a conservative capital structure and ample equity buffer to absorb earnings volatility.
Interest coverage at 6.79× surpasses the 5× strong benchmark, showing that operating earnings comfortably cover interest obligations and reducing default risk even if earnings dip modestly.
Free cash flow as a percentage of revenue is only 3.19%, far short of the 10% target for robust cash generation, suggesting limited excess cash after reinvestment needs.

Balance Sheet & Cash Flow Health

SiriusPoint Ltd. (SPNT) — Cash Flow

Cash Flow Statement ($M)

Year	Operating CF	Investing CF	Financing CF	CapEx	Free Cash Flow	Buybacks	Dividends
2025	$102M	$424M	$-519M		$102M
2024	$75M	$344M	$-625M		$75M	$-300M	$-16M
2023	$581M	$-332M	$-62M		$581M
2022	$293M	$-1304M	$-24M	$-1M	$292M	$-12M
2021	$2M	$209M	$24M		$2M
2020	$73M	$6M	$-19M		$73M	$-0M	$-1M
2019	$141M	$787M	$13M		$141M		$-3M
2018	$13M	$378M	$-227M		$13M	$-139M	$-3M
2017	$-79M	$23M	$54M		$-79M	$-41M	$-3M
2016	$5M	$-53M	$38M		$5M	$-7M	$-0M
2015	$188M	$-164M	$-32M		$188M		$-0M

Cash Flow Trends

A Piotroski F‑Score of 7 out of 9 places SiriusPoint in the top tier of financially sound firms, indicating strong profitability, cash flow, and operational efficiency trends.
The Altman Z‑score of 0.98 falls well below the 1.8 distress threshold, flagging a high probability of bankruptcy within two years despite other balance sheet strengths.
Operating cash flow to net income ratio of 0.22 is far beneath the 1.0 benchmark, revealing that earnings are not being fully converted into cash and raising concerns about earnings quality.

Balance Sheet & Cash Flow Health

SiriusPoint Ltd. (SPNT) — FCF & Capital Returns

Free Cash Flow Statistics

Buyback & Dividend Trends

A Piotroski F‑Score of 7 out of 9 places SiriusPoint in the top tier of financially sound firms, indicating strong profitability, cash flow, and operational efficiency trends.
The Altman Z‑score of 0.98 falls well below the 1.8 distress threshold, flagging a high probability of bankruptcy within two years despite other balance sheet strengths.
Operating cash flow to net income ratio of 0.22 is far beneath the 1.0 benchmark, revealing that earnings are not being fully converted into cash and raising concerns about earnings quality.

Executive Insights & Key Takeaways

Key Takeaways

1Y Return

▲ +13.4%

vs S&P -10.3pp

Revenue 3Y CAGR

▲ +13.9%

5Y: +29.4%

Net Margin

14.3%

▲ 3Y ago: -17.8%

ROIC

15.0%

▲ 3Y ago: -75.0%

FCF Margin

3.2%

▼ 3Y ago: 13.5%

Piotroski

7/9

Strong

SiriusPoint delivered a solid 13.4% total return over the past year, outpacing many peers but still lagging the S&P 500 by roughly 10 percentage points on an excess‑return basis. The company’s top line is expanding rapidly, with revenue of $3.2 bn growing 22.6% YoY and a 13.9% three‑year CAGR, while margins remain healthy—gross profit at 52.6% and net margin at 14.3%. Profitability metrics are robust: ROE stands at 18.6%, ROIC at 15.0%, and the Piotroski score of 7/9 signals strong operating performance. Balance‑sheet fundamentals support this growth, evidenced by a current ratio of 1.59, low leverage (D/E = 0.28), and ample interest coverage of 6.8×, though the Altman Z‑score of 1.0 flags emerging distress risk. Collectively, strong earnings generation, disciplined capital structure, and high institutional ownership (83.5%) underpin a cautiously optimistic investment thesis.

✅ Strengths

Revenue is accelerating at 22.6% YoY, driving a 13.9% three‑year CAGR that expands the earnings base and supports higher future cash flows.
High profitability—gross margin of 52.6% and net margin of 14.3%—means each dollar of sales contributes substantially to bottom‑line growth, reinforcing return on equity at 18.6%.
Leverage is modest (D/E = 0.28) with an interest coverage ratio of 6.8×, providing ample headroom to service debt and fund organic expansion without diluting shareholders.
Institutional ownership of 83.5% aligns management incentives with investors and suggests confidence from sophisticated capital providers.

⚠️ Risks

The stock’s beta of 0.62 indicates limited upside in bullish markets, contributing to a 1‑year excess return that is 10.3% below the S&P 500.
A cash conversion cycle of 154 days and free‑cash‑flow margin of only 3.2% suggest working‑capital intensity could constrain liquidity during revenue slowdowns.
The Altman Z‑score of 1.0 places SiriusPoint near the distress threshold, implying heightened vulnerability to adverse macroeconomic shocks or earnings volatility.
Operating cash flow covers just 22.3% of net income (OCF/NI = 0.223), indicating that a sizable portion of earnings is non‑cash and could mask underlying profitability pressures.

SPNT

Related Reports

Visit finexus.net/reports for Valuation, Return & Risk, and other reports

Report written 2026-06-07 • Finexus

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.